Brief: Puma Biotechnology Reports First Quarter 2022 Financial Results
May 5 (Reuters) - Puma Biotechnology Inc PBYI.O :
* PUMA BIOTECHNOLOGY REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
* Q1 ADJUSTED NON-GAAP LOSS PER SHARE $0.01
* Q1 GAAP LOSS PER SHARE $0.08
Source text for Eikon: ID:nBwbJq1k4a
Further company coverage: PBYI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Puma Biotechnology
See all newsBrief: Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(C)(4)
Brief: Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
Puma Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Corrected: Puma Biotechnology lifts 2026 outlook as Q2 revenue rises on NERLYNX demand
Brief: Puma Biotechnology Q2 Adjusted EPS USD 0.2